CDK inhibitor

This page covers all CDK inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CDK4/6, CDK9.

Targets

CDK4/6 · CDK9

Marketed (1)

• Palbociclib in combination with AI · Pfizer · Oncology · 4122

Phase 3 pipeline (1)

• TPX-114 · Tego Science, Inc. · Oncology
  TPX-114 is a small molecule inhibitor of the CDK9 enzyme.

Phase 2 pipeline (3)

• Initiation of ribociclib · Shirley Vichy Wang · Oncology
  CDK4/6 inhibitor
• DYV700 · Dyve Biosciences, Inc. · Oncology
  DYV700 is a small molecule inhibitor of the CDK9 enzyme.
• ASP8477 · Astellas Pharma Europe B.V. · Oncology
  ASP8477 is a small molecule that targets the CDK9 protein.